Maturation of dendritic cells determines whether an antigenwill elicit a tolerogenic or immunogenic response. Endogenous pathways are required to maintain peripheral tolerance to self-antigens by deleting, anergizing or expanding T regulatory cells. Work during the past funding period of this program project revealed that IgG immune complexes can promotestrongly immunogenic responses if the normalinhibitory constraint is overcome. We will test the hypothesisthat IgG immune complexes, in the steadystate, maintain tolerance through distinct DC subsets by preferentially eliciting inhibitory receptor signaling. This endogenous pathwayhas been shown to be perturbed in autoimmune susceptible mouse strains and human population. This hypothesiswill be tested by 1) Determining the contribution of the inhibitory FcR expressed on DCsubsets to the autoimmune phenotype;2) Blocking activation or inhibitory FcR signaling on DCs in novel FcR humanized mouse models to determine their contribution to develop or maintenance of autoimmunity and 3) Dissecting the FcR signaling pathway on DCs that either promotes immunity or tolerance and its potential synergy with TLR signaling pathways. These studies will depend on the reagents and observations developed in the two other projects in this program project. The results of the studies in this projectwill, in turn, impact on the experimental approachesof the other projects. This synergy will allow us to developapproachesto restore tolerance in autoimmunity through the targeting and manipulationof maturationpathways in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI051573-08
Application #
7905128
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
8
Fiscal Year
2009
Total Cost
$390,328
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Sela, Uri; Park, Chae Gyu; Park, Andrew et al. (2016) Dendritic Cells Induce a Subpopulation of IL-12R?2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses. PLoS One 11:e0146412
Guermonprez, Pierre; Helft, Julie; Claser, Carla et al. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 19:730-8
Schreiber, Heidi A; Loschko, Jakob; Karssemeijer, Roos A et al. (2013) Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium. J Exp Med 210:2025-39
Bozzacco, Leonia; Yu, Haiqiang (2013) Identification and quantitation of MHC class II-bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis. Methods Mol Biol 1061:231-43
Bozzacco, Leonia; Yu, Haiqiang; Dengjel, Jorn et al. (2012) Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. PLoS One 7:e41897
Meredith, Matthew M; Liu, Kang; Kamphorst, Alice O et al. (2012) Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 209:1583-93
Meredith, Matthew M; Liu, Kang; Darrasse-Jeze, Guillaume et al. (2012) Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209:1153-65
Wang, Bei; Zaidi, Neeha; He, Li-Zhen et al. (2012) Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Res 14:R39
Bozzacco, Leonia; Yu, Haiqiang; Zebroski, Henry A et al. (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 10:5016-30
Li, Fubin; Ravetch, Jeffrey V (2011) Inhibitory Fc? receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 333:1030-4

Showing the most recent 10 out of 40 publications